Details of the Drug Formulations

General Information of Drug (ID: DMIJC9X)

• Drug Name: Osilodrostat Drug Info
• Synonyms: LCI699; 928134-65-0; LCI-699; UNII-5YL4IQ1078; CHEMBL3099695; 5YL4IQ1078; Osilodrostat;4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile; 1304733-26-3; Osilodrostat [USAN:INN]; LCI 699; Osilodrostat (USAN/INN); LCI699-NX; GTPL8310; SCHEMBL12460772; DTXSID40156570; MolPort-044-560-410; EX-A1397; ZINC72318114; s7456; BDBM50444549; AKOS027323750; DB11837; CS-6896; HY-16276; KB-78108; Z-3271; D11061; 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzo nitrile

Indication

Disease Entry	ICD 11	Status	REF
Cushing disease	5A70	Approved	[1]

• Cross-matching ID:
  PubChem CID: 44139752
  CAS Number: 928134-65-0
  TTD ID: D03AJU
  ACDINA ID: D01304

Full List of Drug Formulations Containing This Drug

Osilodrostat eq 10mg base tablet

Company	Formulation ID	FDA Description
Recordati Rare Disease	F23849	Colloidal Silicon Dioxide; Croscarmellose Sodium; Mannitol; Microcrystalline Cellulose; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Yellow); Ferric Oxide (Red); Ferrosoferric Oxide; Polyethylene Glycol 4000; Talc

Osilodrostat eq 1mg base tablet

Company	Formulation ID	FDA Description
Recordati Rare Disease	F23850	Colloidal Silicon Dioxide; Croscarmellose Sodium; Mannitol; Microcrystalline Cellulose; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Yellow); Ferric Oxide (Red); Polyethylene Glycol 4000; Talc.

Osilodrostat eq 5mg base tablet

Company	Formulation ID	FDA Description
Recordati Rare Disease	F23851	Colloidal Silicon Dioxide; Croscarmellose Sodium; Mannitol; Microcrystalline Cellulose; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Yellow); Polyethylene Glycol 4000; Talc.

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020